Streetbeat News

Analyst Ratings

RCL

Truist Securities analyst Patrick Scholes maintains a Hold rating on Royal Caribbean Gr (NYSE:RCL) and raises the price target from $72 to $85.

Portfolio Pulse from Benzinga Newsdesk

May 30, 2023 | 11:24 am

CCL

Truist Securities analyst Patrick Scholes maintains a Sell rating on Carnival (NYSE:CCL) and raises the price target from $10 to $11.

Portfolio Pulse from Benzinga Newsdesk

May 30, 2023 | 11:24 am

ACVA

B of A Securities analyst Nat Schindler maintains a Buy rating on ACV Auctions (NASDAQ:ACVA) and raises the price target from $15.5 to $18.

Portfolio Pulse from Benzinga Newsdesk

May 30, 2023 | 11:23 am

HIMS

Piper Sandler analyst Michael Lavery maintains a Neutral rating on Hims & Hers Health (NYSE:HIMS) and lowers the price target from $12 to $11.

Portfolio Pulse from Benzinga Newsdesk

May 30, 2023 | 11:22 am

NTRA

Piper Sandler analyst David Westenberg maintains an Overweight rating on Natera (NASDAQ:NTRA) but lowers the price target from $80 to $70.

Portfolio Pulse from Benzinga Newsdesk

May 30, 2023 | 11:15 am

BAX

Morgan Stanley analyst Patrick Wood assumes Baxter Intl (NYSE:BAX) with an Equal-Weight rating and announces a price target of $45.

Portfolio Pulse from richadhand@benzinga.com

May 30, 2023 | 11:09 am

BDX

Morgan Stanley analyst Patrick Wood has assumed coverage of Becton, Dickinson (NYSE:BDX) with an Overweight rating and a price target of $295.

Portfolio Pulse from richadhand@benzinga.com

May 30, 2023 | 11:08 am

CRVS

Ladenburg Thalmann analyst Aydin Huseynov maintains a Buy rating on Corvus Pharma (NASDAQ:CRVS) and raises the price target from $4 to $10.

Portfolio Pulse from Benzinga Newsdesk

May 30, 2023 | 11:08 am

VRDN

RBC Capital analyst Gregory Renza initiates coverage on Viridian Therapeutics (NASDAQ:VRDN) with an Outperform rating and a price target of $44.

Portfolio Pulse from richadhand@benzinga.com

May 30, 2023 | 11:07 am

CRWD

Rosenblatt analyst Catharine Trebnick reiterates a Buy rating on CrowdStrike Holdings (NASDAQ:CRWD) and maintains a $170 price target.

Portfolio Pulse from Benzinga Newsdesk

May 30, 2023 | 11:06 am